Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT05114668
Title Safety, Tolerability, and Pharmacokinetics of EVT801 in Patients With Advanced Solid Tumours
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Kazia Therapeutics Limited
Indications

renal cell carcinoma

sarcoma

Advanced Solid Tumor

Therapies

EVT801

Age Groups: adult | senior
Covered Countries FRA


No variant requirements are available.